inFoods® IBS
Irritable Bowel Syndrome (IBS)
FDA PMA Clinical StudyActive - Pivotal
Key Facts
Indication
Irritable Bowel Syndrome (IBS)
Phase
FDA PMA Clinical Study
Status
Active - Pivotal
Company
About Biomerica
Biomerica is a publicly traded diagnostics company with a 40+ year history, specializing in immunoassay-based tests for chronic conditions. Its flagship innovation is the inFoods® IBS program, a diagnostic-guided therapy designed to identify food triggers for Irritable Bowel Syndrome patients. The company's strategy leverages its FDA and CE-certified manufacturing capabilities to both commercialize proprietary products and provide contract services, aiming to capture value in the large, underserved IBS market.
View full company profileTherapeutic Areas
Other Irritable Bowel Syndrome (IBS) Drugs
| Drug | Company | Phase |
|---|---|---|
| Astressin Platform | Sentia Medical Sciences | Pre-clinical |